Clinical trial
Effects of Hemofiltration and Mannitol Treatment on Cardiopulmonary-Bypass…
NCT00426192 · University Hospital, Saarland, Other · Unknown status
Key facts
| NCT number | NCT00426192 |
|---|---|
| Title | Effects of Hemofiltration and Mannitol Treatment on Cardiopulmonary-Bypass Induced Immunosuppression |
| Official title | Mechanisms of Endotoxin-Tolerance of Human Monocytes After CABG-Sugery - Effects of Hemofiltration and Mannitol Treatment |
| Lead sponsor | University Hospital, Saarland, Other |
| Collaborators | Else Kröner Fresenius Foundation |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Inflammation |
| Intervention type | Drug, Procedure |
| Interventions | i.v. mannitol, hemofiltration |
| Enrollment | 52 |
| Start date | Oct 1, 2003 |
| Completion | Nov 1, 2004 |
| First posted | Jan 24, 2007 |
| Last update posted | Jan 24, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: